Index DJIA, S&P 500
P/E 11.51
EPS (ttm) 6.87
Insider Own 0.07%
Shs Outstand 2.52B
Perf Week -3.37%
Market Cap 198.52B
Forward P/E 8.14
EPS next Y 9.71
Insider Trans -0.19%
Shs Float 2.51B
Perf Month 1.40%
Income 17.43B
PEG 0.99
EPS next Q 2.06
Inst Own 80.30%
Short Float 1.38%
Perf Quarter -16.54%
Sales 63.78B
P/S 3.11
EPS this Y 16.31%
Inst Trans 0.63%
Short Ratio 2.11
Perf Half Y -20.99%
Book/sh 19.21
P/B 4.12
EPS next Y 9.18%
ROA 15.78%
Short Interest 34.56M
Perf Year -37.99%
Cash/sh 3.72
P/C 21.28
EPS next 5Y 11.64%
ROE 39.31%
52W Range 73.31 - 134.63
Perf YTD -20.53%
Dividend Est. 3.13 (3.96%)
P/FCF 11.65
EPS past 5Y 12.04%
ROIC 21.31%
52W High -41.28%
Beta 0.40
Dividend TTM 3.20 (4.05%)
Quick Ratio 1.16
Sales past 5Y 6.55%
Gross Margin 74.68%
52W Low 7.84%
ATR (14) 2.04
Dividend Ex-Date Jun 16, 2025
Current Ratio 1.41
EPS Y/Y TTM 654.93%
Oper. Margin 34.71%
RSI (14) 49.43
Volatility 1.93% 1.42%
Employees 75000
Debt/Eq 0.72
Sales Y/Y TTM 4.40%
Profit Margin 27.33%
Recom 1.88
Target Price 102.10
Option/Short Yes / Yes
LT Debt/Eq 0.69
EPS Q/Q 7.20%
Payout 46.32%
Rel Volume 2.06
Prev Close 79.29
Sales Surprise 1.24%
EPS Surprise 4.09%
Sales Q/Q -1.20%
Earnings Apr 24 BMO
Avg Volume 16.38M
Price 79.06
SMA20 0.53%
SMA50 0.09%
SMA200 -16.65%
Trades
Volume 33,767,778
Change -0.29%
Date
Action
Analyst
Rating Change
Price Target Change
May-14-25 Downgrade
Citigroup
Buy → Neutral
$84
Apr-22-25 Initiated
Cantor Fitzgerald
Neutral
$85
Feb-18-25 Downgrade
Deutsche Bank
Buy → Hold
$128 → $105
Feb-10-25 Downgrade
TD Cowen
Buy → Hold
$121 → $100
Jan-08-25 Downgrade
Truist
Buy → Hold
$110
Dec-20-24 Downgrade
BMO Capital Markets
Outperform → Market Perform
$136 → $105
Dec-10-24 Resumed
BofA Securities
Buy
$121
Dec-04-24 Upgrade
HSBC Securities
Hold → Buy
$130
Nov-15-24 Initiated
Wolfe Research
Peer Perform
Nov-11-24 Downgrade
Daiwa Securities
Buy → Neutral
Oct-17-24 Initiated
Bernstein
Mkt Perform
$115
Mar-11-24 Downgrade
Societe Generale
Hold → Sell
$104
Jan-04-24 Upgrade
TD Cowen
Market Perform → Outperform
$125 → $135
Nov-09-23 Initiated
Deutsche Bank
Buy
$115
Oct-27-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$132
Oct-20-23 Upgrade
UBS
Neutral → Buy
$117 → $122
Jul-14-23 Initiated
HSBC Securities
Hold
$123
Apr-13-23 Upgrade
Citigroup
Neutral → Buy
$105 → $130
Mar-28-23 Downgrade
Societe Generale
Buy → Hold
Mar-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $115
Show Previous Ratings
Jun-20-25 02:06PM
08:00AM
Jun-19-25 09:47AM
12:05AM
Jun-18-25 05:45PM
12:46PM
Loading…
12:46PM
10:00AM
09:18AM
09:13AM
07:00AM
05:02AM
03:11AM
Jun-17-25 05:50PM
02:39PM
11:20AM
08:04AM
Loading…
08:04AM
Jun-16-25 09:30AM
Jun-15-25 05:47AM
Jun-14-25 08:02AM
Jun-13-25 07:31PM
12:45PM
11:00AM
09:47AM
07:00AM
06:45AM
05:31AM
Jun-12-25 04:45PM
10:21AM
06:45AM
Jun-11-25 05:45PM
04:51PM
Loading…
04:51PM
11:30AM
10:20AM
09:36AM
05:41AM
Jun-10-25 08:02PM
05:50PM
10:50AM
09:46AM
08:18AM
Jun-09-25 03:11PM
02:15PM
12:03PM
11:08AM
06:45AM
05:05AM
Jun-07-25 04:30AM
Jun-06-25 04:16PM
09:16AM
Jun-05-25 11:28AM
09:19AM
Jun-04-25 05:45PM
12:06PM
12:03PM
10:18AM
08:55AM
08:50AM
06:45AM
Jun-03-25 09:33AM
09:27AM
(Investor's Business Daily)
07:38AM
06:30AM
Jun-02-25 11:46AM
10:53AM
09:38AM
09:22AM
08:46AM
02:45AM
May-31-25 08:00AM
May-30-25 12:43PM
11:09AM
10:00AM
09:22AM
(Investor's Business Daily)
08:05AM
08:00AM
May-29-25 09:18AM
09:00AM
07:36AM
07:00AM
06:21AM
May-27-25 01:24PM
08:17AM
May-26-25 11:01AM
09:16AM
May-23-25 10:15AM
(Investor's Business Daily)
08:16AM
May-22-25 08:46AM
07:15AM
06:45AM
May-21-25 11:28AM
09:05AM
May-20-25 10:22AM
08:46AM
May-19-25 09:51AM
08:29AM
07:00AM
06:20AM
May-18-25 08:31PM
(The Wall Street Journal)
May-16-25 08:06AM
06:45AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Smart Dalton E. III SVP Fin. - Global Controller May 03 '25 Option Exercise 83.18 2,050 170,519 10,127 May 05 04:23 PM Smart Dalton E. III SVP Fin. - Global Controller Apr 30 '25 Option Exercise 84.71 464 39,305 8,242 May 02 04:18 PM Smart Dalton E. III SVP Fin. - Global Controller May 02 '25 Option Exercise 83.26 381 31,722 8,464 May 02 04:18 PM Romanelli Joseph President, Human Health Int?l May 02 '25 Option Exercise 83.26 2,262 188,334 24,061 May 02 04:14 PM Romanelli Joseph President, Human Health Int?l Apr 30 '25 Option Exercise 84.71 2,063 174,757 22,816 May 02 04:14 PM Larson Betty D EVP, Chief HR Officer Apr 30 '25 Option Exercise 84.71 11,350 961,458 11,350 May 02 04:12 PM Smart Dalton E. III SVP Fin. - Global Controller Apr 25 '25 Option Exercise 58.08 5,000 290,400 12,040 Apr 29 04:04 PM Smart Dalton E. III SVP Fin. - Global Controller Apr 25 '25 Sale 82.76 4,262 352,723 7,778 Apr 29 04:04 PM DALTON SMART Officer Apr 25 '25 Proposed Sale 82.76 4,262 352,723 Apr 25 04:05 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 19 '25 Sale 84.09 8,500 714,745 30,705 Feb 20 04:01 PM JOHANNES JACOBUS OOSTHUIZEN Officer Feb 19 '25 Proposed Sale 84.09 8,500 714,745 Feb 19 05:09 PM DAVID WILLIAMS Officer Feb 13 '25 Proposed Sale 85.34 6,000 512,057 Feb 13 04:10 PM Williams David Michael EVP,Chief Info&Digital Officer Feb 13 '25 Sale 85.34 6,000 512,057 24,123 Feb 13 04:01 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 08 '25 Option Exercise 87.28 13,002 1,134,815 45,609 Feb 11 02:59 PM THULIN INGE G Director Feb 06 '25 Buy 88.25 2,833 250,000 2,933 Feb 07 04:09 PM Downing Cristal N Chief Comm. & Public Afrs Ofcr Feb 06 '25 Sale 88.76 2,361 209,551 7,085 Feb 07 04:07 PM BAKER DOUGLAS M JR Director Feb 05 '25 Buy 88.50 15,000 1,327,500 16,000 Feb 07 04:04 PM CRISTAL DOWNING Officer Feb 06 '25 Proposed Sale 88.76 2,361 209,551 Feb 06 04:43 PM Guindo Chirfi Chief Marketing Officer Aug 05 '24 Option Exercise 115.20 36,901 4,250,995 57,782 Aug 06 12:20 PM